ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call
ICU Medical (NASDAQ: ICUI) has scheduled its first quarter 2025 earnings release and conference call for Thursday, May 8, 2025. The company will release its Q1 2025 results at approximately 4:00 p.m. ET, followed by a conference call at 4:30 p.m. ET.
Investors can access the call via phone at (800) 225-9448 using conference ID 'ICUMED'. Additionally, a simultaneous webcast will be available through the Investors section of the company's website at www.icumed.com, with replay options available.
ICU Medical (NASDAQ: ICUI) ha programmato la pubblicazione dei risultati del primo trimestre 2025 e la conferenza telefonica per giovedì 8 maggio 2025. L'azienda comunicherà i dati del Q1 2025 intorno alle 16:00 ET, seguiti da una conference call alle 16:30 ET.
Gli investitori potranno partecipare alla chiamata telefonando al numero (800) 225-9448 e utilizzando l'ID conferenza 'ICUMED'. Inoltre, sarà disponibile una webcast simultanea nella sezione Investitori del sito web aziendale www.icumed.com, con possibilità di riascolto.
ICU Medical (NASDAQ: ICUI) ha programado la publicación de sus resultados del primer trimestre de 2025 y la conferencia telefónica para el jueves 8 de mayo de 2025. La compañía dará a conocer sus resultados del Q1 2025 alrededor de las 4:00 p.m. ET, seguida de una llamada de conferencia a las 4:30 p.m. ET.
Los inversores podrán acceder a la llamada por teléfono al (800) 225-9448 usando el ID de conferencia 'ICUMED'. Además, habrá una transmisión simultánea vía webcast en la sección de Inversores del sitio web de la empresa www.icumed.com, con opciones para reproducción.
ICU Medical (NASDAQ: ICUI)는 2025년 1분기 실적 발표 및 컨퍼런스 콜을 2025년 5월 8일 목요일로 예정했습니다. 회사는 약 동부시간 오후 4시에 1분기 2025 실적을 발표하며, 오후 4시 30분에 컨퍼런스 콜이 진행됩니다.
투자자들은 전화번호 (800) 225-9448로 컨퍼런스 ID 'ICUMED'를 사용해 전화 참여할 수 있습니다. 또한 회사 웹사이트 www.icumed.com의 투자자 섹션에서 동시 웹캐스트가 제공되며, 다시보기 기능도 이용 가능합니다.
ICU Medical (NASDAQ : ICUI) a programmé la publication de ses résultats du premier trimestre 2025 ainsi que la conférence téléphonique pour le jeudi 8 mai 2025. La société communiquera ses résultats du T1 2025 vers 16h00 ET, suivis d'une conférence téléphonique à 16h30 ET.
Les investisseurs pourront accéder à l’appel par téléphone au (800) 225-9448 en utilisant l’identifiant de conférence 'ICUMED'. De plus, un webcast simultané sera disponible dans la section Investisseurs du site web de la société www.icumed.com, avec des options de replay.
ICU Medical (NASDAQ: ICUI) hat die Veröffentlichung der Ergebnisse für das erste Quartal 2025 und die Telefonkonferenz für Donnerstag, den 8. Mai 2025, geplant. Das Unternehmen wird die Q1 2025-Ergebnisse gegen 16:00 Uhr ET bekanntgeben, gefolgt von einer Telefonkonferenz um 16:30 Uhr ET.
Investoren können die Telefonkonferenz unter der Nummer (800) 225-9448 mit der Konferenz-ID 'ICUMED' verfolgen. Zusätzlich wird ein gleichzeitiger Webcast im Investor-Bereich der Unternehmenswebsite www.icumed.com angeboten, mit Wiedergabeoptionen.
- None.
- None.
SAN CLEMENTE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2025 earnings release and conference call.
The Company will release its first quarter 2025 results on Thursday, May 8, 2025 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Thursday, May 8, 2025. The call can be accessed at (800) 225-9448, conference ID “ICUMED”. The conference call will be simultaneously available by webcast, which can be accessed by going to the Company's website at www.icumed.com, clicking on the Investors tab, clicking on the Webcast icon and following the prompts. The webcast will also be available by replay.
About ICU Medical
ICU Medical (Nasdaq: ICUI) is a global leader in infusion systems, infusion consumables and high-value critical care products used in hospital, alternate site and home care settings. Our team is focused on providing quality, innovation and value to our clinical customers worldwide. ICU Medical is headquartered in San Clemente, California. More information about ICU Medical can be found at www.icumed.com.
CONTACT:
ICU Medical, Inc.
Brian Bonnell, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Managing Partner
(646) 277-1254
Source: ICU Medical, Inc.
FAQ
When will ICU Medical (ICUI) release Q1 2025 earnings?
How can investors join ICU Medical's Q1 2025 earnings call?
What time is ICU Medical's Q1 2025 earnings conference call?
Will ICU Medical's Q1 2025 earnings call be available for replay?
